Annual D&A
$860.90 K
-$2.60 M-75.15%
December 31, 2022
Summary
- As of February 10, 2025, LMNL annual depreciation & amortization is $860.90 thousand, with the most recent change of -$2.60 million (-75.15%) on December 31, 2022.
- During the last 3 years, LMNL annual D&A has fallen by -$6.60 million (-88.47%).
Performance
LMNL Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Related metrics
Quarterly D&A
$174.30 K
-$10.50 K-5.68%
June 30, 2023
Summary
- As of February 10, 2025, LMNL quarterly depreciation & amortization is $174.30 thousand, with the most recent change of -$10.50 thousand (-5.68%) on June 30, 2023.
- Over the past year, LMNL quarterly D&A has dropped by -$39.80 thousand (-18.59%).
Performance
LMNL Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Related metrics
TTM D&A
$779.30 K
-$39.80 K-4.86%
June 30, 2023
Summary
- As of February 10, 2025, LMNL TTM depreciation & amortization is $779.30 thousand, with the most recent change of -$39.80 thousand (-4.86%) on June 30, 2023.
- Over the past year, LMNL TTM D&A has dropped by -$863.30 thousand (-52.56%).
Performance
LMNL TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Related metrics
LMNL Depreciation And Amortization Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -75.2% | -18.6% | -52.6% |
3 y3 years | -88.5% | -89.9% | -88.4% |
5 y5 years | -75.6% | -84.0% | -89.6% |
LMNL Depreciation And Amortization Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -75.2% | at low | -72.0% | at low | -77.5% | at low |
5 y | 5-year | -88.5% | at low | -90.4% | at low | -89.6% | at low |
alltime | all time | -88.5% | -92.2% | -91.1% | -62.5% | -89.6% | -81.8% |
Liminal BioSciences Depreciation And Amortization History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2023 | - | $174.30 K(-5.7%) | $779.30 K(-4.9%) |
Mar 2023 | - | $184.80 K(-15.9%) | $819.10 K(-4.8%) |
Dec 2022 | $860.90 K(-75.2%) | $219.80 K(+9.7%) | $860.80 K(-31.8%) |
Sep 2022 | - | $200.40 K(-6.4%) | $1.26 M(-23.1%) |
Jun 2022 | - | $214.10 K(-5.5%) | $1.64 M(-38.5%) |
Mar 2022 | - | $226.50 K(-63.6%) | $2.67 M(-22.9%) |
Dec 2021 | $3.46 M(-45.0%) | $621.70 K(+7.1%) | $3.46 M(-22.7%) |
Sep 2021 | - | $580.30 K(-53.3%) | $4.48 M(-20.4%) |
Jun 2021 | - | $1.24 M(+21.6%) | $5.63 M(-7.9%) |
Mar 2021 | - | $1.02 M(-37.6%) | $6.11 M(-3.1%) |
Dec 2020 | $6.30 M(-15.5%) | $1.64 M(-5.3%) | $6.30 M(-2.7%) |
Sep 2020 | - | $1.73 M(+0.4%) | $6.48 M(-3.5%) |
Jun 2020 | - | $1.72 M(+41.8%) | $6.72 M(-1.9%) |
Mar 2020 | - | $1.21 M(-32.9%) | $6.85 M(-8.3%) |
Dec 2019 | $7.46 M(+77.2%) | $1.81 M(-7.9%) | $7.46 M(+10.4%) |
Sep 2019 | - | $1.97 M(+6.1%) | $6.76 M(+16.7%) |
Jun 2019 | - | $1.85 M(+1.3%) | $5.80 M(+15.3%) |
Mar 2019 | - | $1.83 M(+65.0%) | $5.03 M(+19.4%) |
Dec 2018 | $4.21 M(+19.3%) | $1.11 M(+10.7%) | $4.21 M(+4.6%) |
Sep 2018 | - | $1.00 M(-7.7%) | $4.03 M(-1.4%) |
Jun 2018 | - | $1.09 M(+7.0%) | $4.08 M(+7.9%) |
Mar 2018 | - | $1.01 M(+9.7%) | $3.79 M(+7.2%) |
Dec 2017 | $3.53 M(+43.9%) | $925.40 K(-12.6%) | $3.53 M(+8.1%) |
Sep 2017 | - | $1.06 M(+34.5%) | $3.27 M(+17.2%) |
Jun 2017 | - | $787.20 K(+3.6%) | $2.79 M(+5.2%) |
Mar 2017 | - | $759.70 K(+14.8%) | $2.65 M(+8.0%) |
Dec 2016 | $2.45 M(+28.5%) | $661.60 K(+14.4%) | $2.45 M(+2.9%) |
Sep 2016 | - | $578.20 K(-11.1%) | $2.39 M(+6.2%) |
Jun 2016 | - | $650.50 K(+15.4%) | $2.25 M(+8.9%) |
Mar 2016 | - | $563.90 K(-5.0%) | $2.06 M(+8.0%) |
Dec 2015 | $1.91 M(+24.4%) | $593.30 K(+35.3%) | $1.91 M(+8.5%) |
Sep 2015 | - | $438.50 K(-6.0%) | $1.76 M(+5.9%) |
Jun 2015 | - | $466.40 K(+13.5%) | $1.66 M(+1.9%) |
Mar 2015 | - | $411.10 K(-7.3%) | $1.63 M(+6.2%) |
Dec 2014 | $1.53 M(+81.8%) | $443.30 K(+30.2%) | $1.53 M(+13.8%) |
Sep 2014 | - | $340.40 K(-21.7%) | $1.35 M(+14.2%) |
Jun 2014 | - | $435.00 K(+37.8%) | $1.18 M(+22.6%) |
Mar 2014 | - | $315.70 K(+22.5%) | $963.10 K(+14.1%) |
Dec 2013 | $843.90 K(+8.3%) | $257.70 K(+49.1%) | $843.90 K(+8.5%) |
Sep 2013 | - | $172.80 K(-20.3%) | $778.00 K(-1.6%) |
Jun 2013 | - | $216.90 K(+10.4%) | $790.60 K(+2.9%) |
Mar 2013 | - | $196.50 K(+2.5%) | $768.10 K(-1.4%) |
Dec 2012 | $779.20 K(+1.6%) | $191.80 K(+3.5%) | $779.20 K(-1.0%) |
Sep 2012 | - | $185.40 K(-4.6%) | $787.20 K(-0.2%) |
Jun 2012 | - | $194.40 K(-6.4%) | $788.40 K(-0.2%) |
Mar 2012 | - | $207.60 K(+3.9%) | $789.70 K(+3.0%) |
Dec 2011 | $766.60 K(+13.3%) | $199.80 K(+7.1%) | $766.70 K(-0.8%) |
Sep 2011 | - | $186.60 K(-4.6%) | $773.10 K(+2.3%) |
Jun 2011 | - | $195.70 K(+6.0%) | $755.80 K(+8.6%) |
Mar 2011 | - | $184.60 K(-10.5%) | $696.10 K(+2.9%) |
Dec 2010 | $676.70 K | $206.20 K(+21.8%) | $676.80 K(-34.8%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2010 | - | $169.30 K(+24.5%) | $1.04 M(-27.5%) |
Jun 2010 | - | $136.00 K(-17.7%) | $1.43 M(-9.8%) |
Mar 2010 | - | $165.30 K(-70.9%) | $1.59 M(-4.9%) |
Dec 2009 | $1.67 M(+19.6%) | $568.00 K(+0.8%) | $1.67 M(+17.4%) |
Sep 2009 | - | $563.30 K(+93.7%) | $1.42 M(+19.2%) |
Jun 2009 | - | $290.80 K(+17.4%) | $1.19 M(-5.9%) |
Mar 2009 | - | $247.80 K(-22.8%) | $1.27 M(-9.2%) |
Dec 2008 | $1.40 M(-50.1%) | $320.90 K(-4.0%) | $1.40 M(-38.1%) |
Sep 2008 | - | $334.20 K(-8.6%) | $2.26 M(-11.6%) |
Jun 2008 | - | $365.60 K(-2.8%) | $2.55 M(-6.2%) |
Mar 2008 | - | $376.00 K(-68.2%) | $2.72 M(-2.7%) |
Dec 2007 | $2.80 M(+6.4%) | $1.18 M(+87.1%) | $2.80 M(+7.0%) |
Sep 2007 | - | $631.00 K(+17.9%) | $2.61 M(+14.3%) |
Jun 2007 | - | $535.40 K(+18.6%) | $2.29 M(-6.1%) |
Mar 2007 | - | $451.50 K(-54.7%) | $2.44 M(-7.3%) |
Dec 2006 | $2.63 M(+10.1%) | $996.30 K(+227.0%) | $2.63 M(+11.5%) |
Sep 2006 | - | $304.70 K(-55.5%) | $2.36 M(-11.0%) |
Jun 2006 | - | $684.70 K(+6.3%) | $2.65 M(+6.4%) |
Mar 2006 | - | $644.10 K(-11.2%) | $2.49 M(+4.3%) |
Dec 2005 | $2.39 M(+13.2%) | $725.30 K(+21.9%) | $2.39 M(+7.0%) |
Sep 2005 | - | $594.90 K(+13.1%) | $2.23 M(+1.4%) |
Jun 2005 | - | $526.00 K(-2.9%) | $2.20 M(+1.6%) |
Mar 2005 | - | $541.70 K(-4.9%) | $2.17 M(+2.7%) |
Dec 2004 | $2.11 M(+7.2%) | $569.60 K(+1.0%) | $2.11 M(-8.0%) |
Sep 2004 | - | $564.10 K(+14.7%) | $2.29 M(+6.6%) |
Jun 2004 | - | $491.70 K(+1.6%) | $2.15 M(+3.1%) |
Mar 2004 | - | $484.10 K(-35.7%) | $2.08 M(+5.9%) |
Dec 2003 | $1.97 M(+149.4%) | $752.30 K(+78.4%) | $1.97 M(+38.5%) |
Sep 2003 | - | $421.60 K(-1.1%) | $1.42 M(+15.1%) |
Jun 2003 | - | $426.30 K(+15.8%) | $1.23 M(+23.6%) |
Mar 2003 | - | $368.10 K(+79.8%) | $998.50 K(+26.5%) |
Dec 2002 | $789.20 K(+26.5%) | $204.70 K(-12.9%) | $789.10 K(-11.8%) |
Sep 2002 | - | $235.00 K(+23.2%) | $894.70 K(+15.6%) |
Jun 2002 | - | $190.70 K(+20.2%) | $774.00 K(+13.1%) |
Mar 2002 | - | $158.70 K(-48.9%) | $684.30 K(+9.7%) |
Dec 2001 | $623.70 K(+58.9%) | $310.30 K(+171.5%) | $623.60 K(+45.6%) |
Sep 2001 | - | $114.30 K(+13.2%) | $428.20 K(+10.1%) |
Jun 2001 | - | $101.00 K(+3.1%) | $388.80 K(-7.8%) |
Mar 2001 | - | $98.00 K(-14.7%) | $421.60 K(+7.4%) |
Dec 2000 | $392.50 K(-51.4%) | $114.90 K(+53.4%) | $392.40 K(-51.9%) |
Sep 2000 | - | $74.90 K(-44.0%) | $816.20 K(+1.2%) |
Jun 2000 | - | $133.80 K(+94.5%) | $806.70 K(-0.5%) |
Mar 2000 | - | $68.80 K(-87.2%) | $810.50 K(+0.3%) |
Dec 1999 | $807.70 K(+1096.6%) | $538.70 K(+723.7%) | $807.80 K(+200.2%) |
Sep 1999 | - | $65.40 K(-52.5%) | $269.10 K(+32.1%) |
Jun 1999 | - | $137.60 K(+108.2%) | $203.70 K(+1.3%) |
Mar 1999 | - | $66.10 K(-51.0%) | $201.10 K(-51.5%) |
Dec 1998 | $67.50 K(-88.4%) | - | - |
Jun 1998 | - | $135.00 K(-2.1%) | $414.90 K(+48.2%) |
Mar 1998 | - | $137.90 K(-2.9%) | $279.90 K(+97.1%) |
Dec 1997 | - | $142.00 K | $142.00 K |
Sep 1997 | $584.10 K | - | - |
FAQ
- What is Liminal BioSciences annual depreciation & amortization?
- What is the all time high annual D&A for Liminal BioSciences?
- What is Liminal BioSciences annual D&A year-on-year change?
- What is Liminal BioSciences quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Liminal BioSciences?
- What is Liminal BioSciences quarterly D&A year-on-year change?
- What is Liminal BioSciences TTM depreciation & amortization?
- What is the all time high TTM D&A for Liminal BioSciences?
- What is Liminal BioSciences TTM D&A year-on-year change?
What is Liminal BioSciences annual depreciation & amortization?
The current annual D&A of LMNL is $860.90 K
What is the all time high annual D&A for Liminal BioSciences?
Liminal BioSciences all-time high annual depreciation & amortization is $7.46 M
What is Liminal BioSciences annual D&A year-on-year change?
Over the past year, LMNL annual depreciation & amortization has changed by -$2.60 M (-75.15%)
What is Liminal BioSciences quarterly depreciation & amortization?
The current quarterly D&A of LMNL is $174.30 K
What is the all time high quarterly D&A for Liminal BioSciences?
Liminal BioSciences all-time high quarterly depreciation & amortization is $1.97 M
What is Liminal BioSciences quarterly D&A year-on-year change?
Over the past year, LMNL quarterly depreciation & amortization has changed by -$39.80 K (-18.59%)
What is Liminal BioSciences TTM depreciation & amortization?
The current TTM D&A of LMNL is $779.30 K
What is the all time high TTM D&A for Liminal BioSciences?
Liminal BioSciences all-time high TTM depreciation & amortization is $7.46 M
What is Liminal BioSciences TTM D&A year-on-year change?
Over the past year, LMNL TTM depreciation & amortization has changed by -$863.30 K (-52.56%)